Dong Mei Su
Director/Board Member at 3SBIO INC.
Net worth: 20 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jing Lou | M | 61 |
Liaoning Sunshine Science & Technology Development Co. Ltd.
Hongkong Sansheng Medical Ltd.
 Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China.
Liaoning Sunshine Bio-Pharmaceutical Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
 Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | 31 years |
| Yan Li Liu | F | 43 |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | 10 years |
| Bin Huang | M | 63 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 years |
| Bo Tan | M | 51 |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 15 years |
| Tian Ruo Pu | M | 55 | 11 years | |
| Dan Zhang | M | 60 | 2 years | |
| Hoi Ti Yang | F | 54 | 3 years | |
| Yong Xu | M | - |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | - |
| Li Tian | F | 41 | 8 years | |
| Fan Zhi Huang | M | 57 | 3 years | |
| Xin Ma | M | 58 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | - |
| Yong Li Jin | M | 66 | 5 years | |
| Hui Hui Li | F | 43 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 11 years |
| Ke Li | M | 56 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China.
Jilin University
| 36 years |
| Yong Fu Chen | M | 67 |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 21 years |
| Siu Kuen Lai | F | 48 | 7 years | |
| Joo Yeow Ng | M | 59 | 2 years | |
| Wei Zhang | F | 62 | 5 years | |
| Hong Cao | F | 55 | 5 years | |
| Jing Wu | F | 29 | 3 years | |
| Yuan Yuan Ren | M | - | - | |
| Dong Tao Luo | M | 48 | 8 years | |
| Zhong Zhe Li | M | - |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | - |
| Peter Mark Patrick O'Kane | M | 68 |
Strategic International Group Ltd.
 Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | - |
| Thomas Kissel | M | - |
Shenyang Pharmaceutical University
| 16 years |
| Feng Zhan Zhang | F | 44 | 4 years | |
| Yong Zhi Sun | F | - | 7 years | |
| Hui Dang | F | 52 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 25 years |
| Xiang He | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shu Hong Pan | F | - |
Jilin University
| 6 years |
| Dong Liu | M | 51 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 6 years |
| Qiang Li | M | 53 |
Jilin University
| 12 years |
| Qian Liu | F | 59 |
Jilin University
| 6 years |
| Wen Yi Huang | M | 53 |
Jilin University
| 7 years |
| Da Cheng Zhao | M | 50 |
Jilin University
| 14 years |
| Lap Yan Wong | M | 53 | 3 years | |
| Rui Wang | M | 60 | - | |
| Hua Xin | M | 58 |
Jilin University
| 6 years |
| David Parkinson | M | 73 | 7 years | |
| Dong Lü | M | 49 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 3 years |
| Jun Ma | M | 61 | 5 years | |
| Wen Wei Dou | M | 58 |
Jilin University
| 7 years |
| Yin Hui Li | M | 56 |
Jilin University
| 4 years |
| Qing Dong Zeng | M | 60 |
Jilin University
| 1 years |
| Jing Gang Zhang | M | 56 |
Jilin University
| 4 years |
| Da Ming Li | M | 57 |
Jilin University
| 4 years |
| Hong Bin Sun | M | 58 |
Jilin University
| 4 years |
| Yuan Zhi Tan | M | 52 |
Jilin University
| 4 years |
| Yang Yu | M | 48 |
Jilin University
| 3 years |
| Ye Li Hao | M | 68 |
Jilin University
| 3 years |
| Lichun Yang | F | - |
Jilin University
| 4 years |
| Qiang Liu | M | 58 |
Jilin University
| 4 years |
| GRANT Chen | M | 60 |
Jilin University
| 1 years |
| Zhi Hua Xu | M | 73 |
Jilin University
| 1 years |
| Qun Yu | M | 56 |
Jilin University
| 4 years |
| Xiaohui Wang | M | 56 |
Jilin University
| 4 years |
| Jian Liu | M | 51 |
Jilin University
| 4 years |
| Cong Yue Su | M | 53 |
Jilin University
| 4 years |
| Yan Song Chang | M | 56 |
Jilin University
| 4 years |
| Shan Qi Zhao | M | 61 |
Jilin University
| 4 years |
| Yuan Zhang | M | 55 |
Jilin University
| 4 years |
| Donglin Song | M | 67 |
Jilin University
| 3 years |
| Lirong Han | M | 61 |
Jilin University
| 1 years |
| Dong Yi Su | M | 58 |
Jilin University
| 4 years |
| Xiang En Shi | M | 68 |
Jilin University
| 3 years |
| Yun Tao Yang | M | 57 |
Jilin University
| 3 years |
| Ying Zhou | M | 58 |
Jilin University
| 4 years |
| Ji Fan Gao | M | 59 |
Jilin University
| 1 years |
| Qiufa Xie | M | 50 |
Jilin University
| 4 years |
| Hang Yu | M | 55 |
Jilin University
| 5 years |
| Peng Cheng Gao | M | 54 |
Jilin University
| 4 years |
| Lin Ying Zang | F | 60 |
Jilin University
| 4 years |
| Zi Yi Xu | F | 54 |
Jilin University
| 4 years |
| Ping Yi Li | M | 57 |
Jilin University
| 4 years |
| Rui Lin Zhang | M | 53 |
Jilin University
| 4 years |
| Shi Ming Zhao | M | 71 |
Jilin University
| 4 years |
| Xiu Feng Yu | M | 60 |
Jilin University
| 3 years |
| Xue Yin Li | M | 51 |
Jilin University
| 4 years |
| Yong Jiang Yu | M | 55 |
Jilin University
| 4 years |
| Zhi Qun Xu | M | 58 |
Jilin University
| 4 years |
| Wei Dong Xu | M | 65 |
Jilin University
| 3 years |
| Qi Ang Kong | M | 49 |
Jilin University
| 4 years |
| Jin Hua Zhang | M | 59 |
Jilin University
| 4 years |
| An Jian Wang | M | 71 |
Jilin University
| 3 years |
| Xiao Hui Wu | M | 47 |
Jilin University
| 4 years |
| Gui Lin Zhao | M | 60 |
Jilin University
| 1 years |
| Guang Yuan Wang | M | 62 |
Jilin University
| 4 years |
| Zheng Mao Zhou | M | 52 |
Jilin University
| 4 years |
| Xue Song Wang | M | 52 |
Jilin University
| 4 years |
| Chun Bo Feng | M | 56 |
Jilin University
| 4 years |
| Bai Sun | M | 67 |
Jilin University
| 1 years |
| Qiong Fu | M | 54 |
Jilin University
| 3 years |
| Ai Guo Kong | M | 57 |
Jilin University
| 4 years |
| Da Yong Sun | M | 48 |
Jilin University
| 4 years |
| Shu Jian Yang | M | 55 |
Jilin University
| 4 years |
| Li Zhu Wang | F | 61 |
Jilin University
| 3 years |
| Xi Hong Wu | M | 57 |
Jilin University
| 4 years |
| Ying Wei Zhu | M | 53 |
Jilin University
| 4 years |
| An Nan Huang | M | 55 |
Jilin University
| 4 years |
| Yanjie Song | M | 58 |
Jilin University
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 87 | 87.00% |
| Cayman Islands | 20 | 20.00% |
| Hong Kong | 4 | 4.00% |
| United Kingdom | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dong Mei Su
- Personal Network
